𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update

✍ Scribed by S. Sockalingam; P. S. Links; S. E. Abbey

Book ID
108886535
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
124 KB
Volume
18
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Analysis of clinical and virological fac
Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C
✍ Dr. J. A. Garson; K. Whitby; R. Deaville; S. Brillanti; M. Foli; C. Masci; M. Mi πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 508 KB

## Abstract Interferon alpha (IFN‐α) therapy is currently the treatment of choice for chronic hepatitis C (HCV) infection, but it fails to achieve a sustained response in approximately 75% of those treated. The factors which determine whether or not an individual will respond to IFN‐α are uncertain

Changes in serum fibrogenesis markers du
Changes in serum fibrogenesis markers during interferon therapy for chronic hepatitis type C
✍ K Ishibashi; T Kashiwagi; A Ito; Y Tanaka; M Nagasawa; T Toyama; S Ozaki; M Nait πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 203 KB

the changes in serum levels of hepatic fibrogenesis markers We serially measured the levels of serum N-terminal caused by interferon therapy for chronic hepatitis. 9,10 peptide of type III procollagen (PIIINP), the 7S domain In this study, the serum levels of PIIINP, IV-7S, and HA of type IV collag